Krzysztof Marczuk
Partner
Attorney-at-law
Krzysztof has extensive experience in securities transactions in the capital market (ECM, DCM, M&A), particularly in conducting public and private offerings, as well as general advice on commercial law, including corporate governance. He advises public companies, selling shareholders, investors, investment companies and investment banks in various types of capital market transactions, including regulatory aspects.
Languages:
BIO
Krzysztof is a lawyer with many years of transaction and regulatory experience. He joined GESSEL in 2007 and has been a partner since 2016. He specializes in raising financing through equity issues in primary and secondary public offerings as well as private placements. He also advises on public and private bond offerings.
He provides day-to-day corporate law services to publicly listed companies in all aspects of commercial law, including commercial contracts, as well as in all capital operations (buy-back, share redemptions, splits, share mergers) and in transformation processes, mergers, demergers and reorganizations within capital groups. He specializes in proceedings before the Polish Financial Supervision Authority, the Warsaw Stock Exchange, and the National Securities Depository, including administrative and criminal proceedings concerning the Market Abuse Regulation (MAR). He advises shareholders and investors on transactions involving divestment or acquisition of significant stakes in public companies (public tender offers, accelerated book building, squeeze outs, delisting).
On an ongoing basis, advises public companies on managing their information policy and in fulfilling their disclosure obligations under MAR. He advises investment companies and investment banks on capital market transactions, including regulatory aspects related to public supervision over the activities of financial institutions.
Experience
Selected projects
- Advised Creotech Quantum S.A., a WSE-listed company, on a public offering of newly issued Series D shares conducted through an accelerated bookbuilding (ABB) process, with a value of PLN 81.2 million
- Advised Creotech Instruments on the spin-off of its quantum business and the WSE listing of Creotech Quantum, with an equity value of approximately PLN 535.6 million
- Advised Synektik, SYN2BIO and mBank (as offering manager) on the spin-off of Synektik’s biotechnology business and the WSE listing of SYN2BIO, with an equity value of approximately PLN 202.5 million
- Advised Cavatina Holding on a prospectus-based bond issuance programme with a total value of up to PLN 250 million, including the approval of the base prospectus by the KNF and the admission of the bonds to trading on the Catalyst market
- Advised DataWalk on a PLN 116.25 million non-prospectus public offering of newly issued shares conducted by way of an accelerated bookbuilding (ABB)
- Advised Cavatina Holding on a PLN 102 million public bond offering under a prospectus-based issuance programme and the admission of the bonds to trading on the Catalyst market operated by the WSE
- Advised Cognor Holding on a PLN 300 million secondary public offering conducted through an accelerated bookbuilding (ABB) process, comprising the sale of existing shares by PS Holdco and newly issued shares
- Advised Bioceltix on two equity offerings with a total value of PLN 116 million, comprising a shareholder-led secondary public offering conducted through an accelerated bookbuilding (ABB) process and the issuance of two tranches of new shares funded with proceeds from the ABB
- Advised cyber_Folks on a non-prospectus public offering of series E shares issued through an accelerated bookbuilding (ABB) process, with a value exceeding PLN 200 million
- Advised Dino Polska on a 1:10 share split and the admission of the shares to trading on the Warsaw Stock Exchange
- Advised Cavatina Holding on a prospectus-based bond issuance programme with a total value of up to PLN 200 million, including the approval of the base prospectus by the KNF
- Advised DataWalk on a non-prospectus public offering of newly issued Series S shares with a total value of approximately PLN 58 million
- Advised Olivia Fin on a bond issue of approximately PLN 40 million under its bond issuance programme and the admission of the bonds to trading on the Catalyst market
- Advised Lithuanian shareholders on the sale of approximately 12.08% of shares in Vercom S.A. through an accelerated bookbuilding (ABB) process, with a value of nearly PLN 300 million
- Advised Creotech Instruments on a PLN 76 million public offering of newly issued shares
- Prospectus of Cavatina Holding S.A. in connection with the initial public offering of shares and their admission to trading (value: PLN 187.5 mln); preparation of an incentive program
- Cavatina Holding S.A. – prospectus in connection with the public offering and bond issue program (values: up to PLN 200 mln)
- Vercom S.A. – prospectus in connection with the initial public offering of shares and their admission to trading (value: PLN 225 mln), preparation of an incentive program
- Kredyt Inkaso S.A. – prospectus in connection with the public offering and bond issue program (value: up to PLN 300 mln)
- Kredyt Inkaso S.A. – prospectus in connection with the public offering and bond issue program (value: up to PLN 100 mln)
- Prospectus of Pure Biologics S.A. in connection with the initial public offering of shares and their admission to trading and change of listing market (value: PLN 54 mln), preparation of an incentive program
- New Energy Investments Sp. z o.o.’s private placement of “green bonds”
- Columbus Energy’s public offering of bonds (program value: up to PLN 200 mln
- Advising REINO Partners, REINO Dividend Plus and Poligo Capital in an M&A transaction involving acquisition of shares in the listed company Graviton Capital and the contribution to that company of majority stakes in REINO Partners and shares in REINO Dividend Plus S.A.
- R22 S.A. prospectus in connection with the initial public offering of shares and their admission to trading (value: PLN 91 mln)
- R22 S.A. prospectus in connection with the secondary public offering with pre- emptive rights of Polimex Mostostal S.A. shares. (value: PLN 114.5 mln)
- Tower Investments S.A.’s prospectus in connection with its initial public offering of shares, and their admission to trading and change of the company’s listing market (value: PLN 54 mln)
- Prospectus in connection with the public offering and admission to trading of shares of DataWalk S.A. (value: PLN 10 mln); subsequent public offerings of the company’s new issue shares (value: PLN 65 mln)
- Prospectus in connection with the public offering and admission to trading of Tesgas S.A. shares (value: PLN 54.5 mln)
- Prospect-free offering and prospectus and change of listing market from the NewConnect ASO market to the regulated market of the Warsaw Stock Exchange of Bioceltix S.A.
- Prospectus in connection with the public offering and admission to trading on the Warsaw Stock Exchange of shares in Skarbiec Holding S.A. (value: PLN 44.3 mln)
- Prospectus in connection with the public offering and admission to trading on the Warsaw Stock Exchange of Vigo System S.A. shares. (value: PLN 53 mln)
- Prospectus and change of listing market from the ASO NewConnect market to the main floor of the Warsaw Stock Exchange of Caspar Asset Management S.A.;
- Compulsory buyout of Elemental Asia S.A. shares by Elemental Holding S.A.
- Prospectus in connection with the public offering and admission to trading on the NewConnect market of Urteste shares (value: PLN 9.52 mln)
- Prospectus in connection with the public offering and admission to trading on the Warsaw Stock Exchange of Bioplanet shares (value: PLN 9.8 mln)
- Public purchases of own shares of ERBUD S.A. (value: PLN 70 mln)
- Advising Haitong Bank Polska in connection with the bond issue program of Polska Grupa Farmaceutyczna S.A. (value: PLN 150 mln)
- Bond issue program of Benefit Systems S.A. and a public offering in connection with the issue of series A and B bonds (value: PLN 100 mln)
- Purchase of treasury shares of CD Projekt S.A. (value: PLN 214 mln), preparation of an incentive program
- Private sale of 32.99% of the shares in the public company Skarbiec Holding S.A. (value: PLN 75 mln)
- ABB shares of X-Trade Brokers Dom Maklerski S.A. (value: PLN 111.2 mln), Pure Biologics share offering, Creepy Jar share offering
- ABB shares in Creepy Jar (value: about PLN 45 mln)
- ABB, private placement and securities loan of Pure Biologics shares (value: PLN 30 mln)
Prospectus in connection with the public offering and admission to trading on the Warsaw Stock Exchange of shares in Polski Bank Komórek Macierzystych S.A. (value: PLN 56.4 mln) - Prospectus in connection with the public offering and admission to trading on the WSE of shares of polWAX S.A. (value: PLN 57.3 mln)
- WB Electronics S.A. bond issue (value: PLN 180 mln)
- Issue of bonds under the bond issuance program of JS Hamilton Poland S.A.
- Purchase of treasury shares through a tender offer for Decora S.A. shares
ii. Public buyback of Unibep S.A.’s own shares - Legal advice on the bond issuance program, secondary public offering of Gino Rossi S.A.
- Danwood Holding S.A. IPO. (transaction cancelled)
IPO of Komex S.A. (transaction suspended) - IPO Expertsender S.A. (transaction suspended)
- IPO of 1C Entertainment S.A. (transaction cancelled)
News
& Insights
18.05.2026
GESSEL advised Creotech Quantum on its public offering of Series D shares
GESSEL advised Creotech Quantum S.A., a company listed on the regulated market of the Warsaw Stock Exchange (WSE), on its public offering of 350,000 Series D shares cond...
20.04.2026
GESSEL advised Creotech Instruments on the spin-off of its quantum business and the WSE listing of Creotech Quantum
GESSEL advised Creotech Instruments S.A. on the spin-off of its quantum business and the listing of Creotech Quantum S.A. on the Main Market of the Warsaw Stock Exchange...
16.04.2026
GESSEL advised on the listing of SYN2BIO on the Warsaw Stock Exchange
GESSEL advised on the project involving the separation of Synektik S.A.’s biotechnology business and the listing of SYN2BIO S.A. on the Main Market of the Warsaw Stock E...
25.03.2026
GESSEL recognised in The Legal 500 EMEA 2026 rankings
GESSEL is recognised in the Legal 500 EMEA 2026 rankings, with 6 practice areas ranked and 5 lawyers recognised in the individual rankings. In addition, 10 lawyers are r...
Education and achievements
- Legal studies at the Faculty of Law and Administration of the Catholic University of Lublin (2004)
Awards
